Format
Sort by
Items per page

Send to

Choose Destination

Best matches for BUPROPION/TU:

Bupropion Use During Pregnancy: A Systematic Review. Hendrick V et al. Prim Care Companion CNS Disord. (2017)

Naltrexone/bupropion for obesity. et al. Drug Ther Bull. (2017)

Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Verbeeck W et al. Cochrane Database Syst Rev. (2017)

Search results

Items: 1 to 20 of 2238

1.

Second-generation antidepressants for preventing seasonal affective disorder in adults.

Gartlehner G, Nussbaumer-Streit B, Gaynes BN, Forneris CA, Morgan LC, Greenblatt A, Wipplinger J, Lux LJ, Van Noord MG, Winkler D.

Cochrane Database Syst Rev. 2019 Mar 18;3:CD011268. doi: 10.1002/14651858.CD011268.pub3.

PMID:
30883669
2.

Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia.

Wilson SM, Thompson AC, Currence ED, Thomas SP, Dedert EA, Kirby AC, Elbogen EB, Moore SD, Calhoun PS, Beckham JC.

Behav Ther. 2019 Mar;50(2):395-409. doi: 10.1016/j.beth.2018.07.004. Epub 2018 Jul 27.

PMID:
30824254
3.

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.

Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116. doi: 10.1097/JCP.0000000000001015.

PMID:
30811371
4.

Relapse prevention interventions for smoking cessation.

Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Hajek P.

Cochrane Database Syst Rev. 2019 Feb 13;2:CD003999. doi: 10.1002/14651858.CD003999.pub5.

PMID:
30758045
5.

Is bupropion useful in the treatment of post-stroke thalamic apathy? A case report and considerations.

Aragona B, De Luca R, Piccolo A, Le Cause M, Destro M, Casella C, Filoni S, Calabrò RS.

Funct Neurol. 2018 Oct/Dec;33(4):213-216.

PMID:
30663968
6.

Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.

Leischow SJ.

JAMA. 2019 Feb 12;321(6):541-542. doi: 10.1001/jama.2018.21557. No abstract available.

PMID:
30653222
7.

Gender-related issues in the pharmacology of new anti-obesity drugs.

Cataldi M, Muscogiuri G, Savastano S, Barrea L, Guida B, Taglialatela M, Colao A.

Obes Rev. 2019 Mar;20(3):375-384. doi: 10.1111/obr.12805. Epub 2018 Dec 27. Review.

PMID:
30589980
8.

Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation.

Tran AX, Ho TT, Varghese Gupta S.

J Clin Pharm Ther. 2019 Apr;44(2):174-179. doi: 10.1111/jcpt.12783. Epub 2018 Dec 21. Review.

PMID:
30578565
9.

Bupropion-Related Exacerbation of Tic Disorder in an Adult: A Case Report.

Lurie I, Ganor O, Mayer G.

Clin Neuropharmacol. 2019 Jan/Feb;42(1):19. doi: 10.1097/WNF.0000000000000312.

PMID:
30499776
10.

In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC-MS/MS analysis.

Varshney E, Tandon M, Saha N, Ali S.

J Pharm Biomed Anal. 2019 Feb 5;164:698-705. doi: 10.1016/j.jpba.2018.11.026. Epub 2018 Nov 16.

PMID:
30472588
11.

Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea.

Yoon W, Shon SH, Hong Y, Joo YH, Lee JS.

J Korean Med Sci. 2018 Oct 19;33(46):e290. doi: 10.3346/jkms.2018.33.e290. eCollection 2018 Nov 12.

12.

The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats.

Menezes CES, McIntyre RS, Chaves Filho AJM, Vasconcelos SMM, de Sousa FCF, Quevedo J, Hyphantis TN, Carvalho AF, Macêdo D.

Pharmacol Rep. 2018 Dec;70(6):1173-1179. doi: 10.1016/j.pharep.2018.07.003. Epub 2018 Jul 21.

PMID:
30321807
13.

Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression.

Lewis CP, Camsari DD, Sonmez AI, Nandakumar AL, Gresbrink MA, Daskalakis ZJ, Croarkin PE.

J Affect Disord. 2019 Feb 1;244:21-24. doi: 10.1016/j.jad.2018.09.079. Epub 2018 Sep 28.

PMID:
30292987
14.

Beliefs and reality of e-cigarette smoking.

Menakuru S, Inzamam Ali M.

BMJ Case Rep. 2018 Oct 2;2018. pii: bcr-2018-225683. doi: 10.1136/bcr-2018-225683.

PMID:
30279252
15.

[Sustained upgaze in a patient who ingested high doses of bupropion. Report of one case].

Cartier R L, Romero O C, Pérez P G.

Rev Med Chil. 2018 May;146(5):665-669. doi: 10.4067/s0034-98872018000500665. Spanish.

16.

Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.

Jha MK, Malchow AL, Grannemann BD, Rush AJ, Trivedi MH.

Neuropsychopharmacology. 2018 Oct;43(11):2197-2203. doi: 10.1038/s41386-018-0180-z. Epub 2018 Aug 15.

PMID:
30135556
17.

Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.

Bozinoff N, Le Foll B.

Expert Rev Respir Med. 2018 Sep;12(9):793-804. doi: 10.1080/17476348.2018.1507736. Epub 2018 Aug 13. Review.

PMID:
30092681
18.

Bupropion Switch for a Depressed Patient With Venlafaxine-Associated Night Sweats.

Kavirajan H.

J Clin Psychopharmacol. 2018 Oct;38(5):536-537. doi: 10.1097/JCP.0000000000000925. No abstract available.

PMID:
30085947
19.

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men.

Yee A, Loh HS, Ong TA, Ng CG, Sulaiman AH.

Am J Mens Health. 2018 Sep;12(5):1705-1718. doi: 10.1177/1557988318784152. Epub 2018 Jul 4.

20.

The influence of selective A1 and A2A receptor antagonists on the antidepressant-like activity of moclobemide, venlafaxine and bupropion in mice.

Bogatko K, Poleszak E, Szopa A, Wyska E, Wlaź P, Świąder K, Wlaź A, Doboszewska U, Rojek K, Serefko A.

J Pharm Pharmacol. 2018 Sep;70(9):1200-1208. doi: 10.1111/jphp.12954. Epub 2018 Jun 25.

PMID:
29943503

Supplemental Content

Loading ...
Support Center